The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation
Background/Aims: The role of the β3-adrenergic receptor (β3-AR) agonist BRL37344 in atrial fibrillation (AF) structural remodeling and the underlying mechanisms as a therapeutic target were investigated. Methods: Four groups of dogs were evaluated: sham, pacing, β3-AR agonist BRL37344 (β3-AGO), and...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-02-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/438647 |
id |
doaj-9317be59bf284c729cc616a7d307450b |
---|---|
record_format |
Article |
spelling |
doaj-9317be59bf284c729cc616a7d307450b2020-11-25T00:11:01ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782016-02-0138251453010.1159/000438647438647The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial FibrillationXiaobing WangRuifeng WangGuangzhong LiuJingmei DongGuanqi ZhaoJingpu TianJiayu SunXiuyue JiaLin WeiYuping WangWeimin LiBackground/Aims: The role of the β3-adrenergic receptor (β3-AR) agonist BRL37344 in atrial fibrillation (AF) structural remodeling and the underlying mechanisms as a therapeutic target were investigated. Methods: Four groups of dogs were evaluated: sham, pacing, β3-AR agonist BRL37344 (β3-AGO), and β3-AR antagonist L748337 (β3-ANT) groups. Dogs in the pacing, β3-AGO and β3-ANT groups were subjected to rapid atrial pacing for four weeks. Atrial structure and function, AF inducibility and duration, atrial myocyte apoptosis and interstitial fibrosis were assessed. Atrial superoxide anions were evaluated by fluorescence microscopy and colorimetric assays. Cardiac nitrate+nitrite levels were used to assess nitric oxide (NO) production. Protein and mRNA expression of β3-AR, neuronal NO synthase (nNOS), inducible NO synthase (iNOS), endothelial NO synthase (eNOS) and guanosine triphosphate cyclohydrolase-1 (GCH-1) as well as tetrahydrobiopterin (BH4) levels were measured. Results: β3-AR was up-regulated in AF. Stimulation of β3-AR significantly increased atrial myocyte apoptosis, fibrosis and atrial dilatation, resulting in increased AF induction and prolonged duration. These effects were attenuated by β3-ANT. Moreover, β3-AGO reduced BH4 and NO production and increased superoxide production, which was inhibited by the specific iNOS inhibitor, 1400w β3-AGO also increased iNOS but decreased eNOS and had no effect on nNOS expression in AF. Conclusions: β3-AR stimulation resulted in atrial structural remodeling by increasing iNOS uncoupling and related oxidative stress. β3-AR up-regulation and iNOS uncoupling might be underlying AF therapeutic targets.http://www.karger.com/Article/FullText/438647Atrial fibrillationβ3-adrenergic receptorAtrial structural remodelingOxidative stressNitric oxide synthaseTetrahydrobiopterin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiaobing Wang Ruifeng Wang Guangzhong Liu Jingmei Dong Guanqi Zhao Jingpu Tian Jiayu Sun Xiuyue Jia Lin Wei Yuping Wang Weimin Li |
spellingShingle |
Xiaobing Wang Ruifeng Wang Guangzhong Liu Jingmei Dong Guanqi Zhao Jingpu Tian Jiayu Sun Xiuyue Jia Lin Wei Yuping Wang Weimin Li The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation Cellular Physiology and Biochemistry Atrial fibrillation β3-adrenergic receptor Atrial structural remodeling Oxidative stress Nitric oxide synthase Tetrahydrobiopterin |
author_facet |
Xiaobing Wang Ruifeng Wang Guangzhong Liu Jingmei Dong Guanqi Zhao Jingpu Tian Jiayu Sun Xiuyue Jia Lin Wei Yuping Wang Weimin Li |
author_sort |
Xiaobing Wang |
title |
The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation |
title_short |
The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation |
title_full |
The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation |
title_fullStr |
The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation |
title_full_unstemmed |
The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation |
title_sort |
β3 adrenergic receptor agonist brl37344 exacerbates atrial structural remodeling through inos uncoupling in canine models of atrial fibrillation |
publisher |
Cell Physiol Biochem Press GmbH & Co KG |
series |
Cellular Physiology and Biochemistry |
issn |
1015-8987 1421-9778 |
publishDate |
2016-02-01 |
description |
Background/Aims: The role of the β3-adrenergic receptor (β3-AR) agonist BRL37344 in atrial fibrillation (AF) structural remodeling and the underlying mechanisms as a therapeutic target were investigated. Methods: Four groups of dogs were evaluated: sham, pacing, β3-AR agonist BRL37344 (β3-AGO), and β3-AR antagonist L748337 (β3-ANT) groups. Dogs in the pacing, β3-AGO and β3-ANT groups were subjected to rapid atrial pacing for four weeks. Atrial structure and function, AF inducibility and duration, atrial myocyte apoptosis and interstitial fibrosis were assessed. Atrial superoxide anions were evaluated by fluorescence microscopy and colorimetric assays. Cardiac nitrate+nitrite levels were used to assess nitric oxide (NO) production. Protein and mRNA expression of β3-AR, neuronal NO synthase (nNOS), inducible NO synthase (iNOS), endothelial NO synthase (eNOS) and guanosine triphosphate cyclohydrolase-1 (GCH-1) as well as tetrahydrobiopterin (BH4) levels were measured. Results: β3-AR was up-regulated in AF. Stimulation of β3-AR significantly increased atrial myocyte apoptosis, fibrosis and atrial dilatation, resulting in increased AF induction and prolonged duration. These effects were attenuated by β3-ANT. Moreover, β3-AGO reduced BH4 and NO production and increased superoxide production, which was inhibited by the specific iNOS inhibitor, 1400w β3-AGO also increased iNOS but decreased eNOS and had no effect on nNOS expression in AF. Conclusions: β3-AR stimulation resulted in atrial structural remodeling by increasing iNOS uncoupling and related oxidative stress. β3-AR up-regulation and iNOS uncoupling might be underlying AF therapeutic targets. |
topic |
Atrial fibrillation β3-adrenergic receptor Atrial structural remodeling Oxidative stress Nitric oxide synthase Tetrahydrobiopterin |
url |
http://www.karger.com/Article/FullText/438647 |
work_keys_str_mv |
AT xiaobingwang theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT ruifengwang theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT guangzhongliu theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT jingmeidong theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT guanqizhao theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT jingputian theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT jiayusun theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT xiuyuejia theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT linwei theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT yupingwang theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT weiminli theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT xiaobingwang b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT ruifengwang b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT guangzhongliu b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT jingmeidong b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT guanqizhao b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT jingputian b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT jiayusun b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT xiuyuejia b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT linwei b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT yupingwang b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation AT weiminli b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation |
_version_ |
1725405637342396416 |